Goldman Sachs Group Inc Procept Bio Robotics Corp Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 550,315 shares of PRCT stock, worth $32.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
550,315
Previous 354,935 55.05%
Holding current value
$32.8 Million
Previous $28.4 Million 55.84%
% of portfolio
0.01%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$67.27 - $99.45 $13.1 Million - $19.4 Million
195,380 Added 55.05%
550,315 $44.3 Million
Q3 2024

Nov 14, 2024
BUY
$56.31 - $84.99 $4.22 Million - $6.37 Million
74,972 Added 26.78%
354,935 $28.4 Million
Q2 2024

Aug 13, 2024
BUY
$45.73 - $69.19 $5.98 Million - $9.05 Million
130,846 Added 87.75%
279,963 $17.1 Million
Q1 2024

May 15, 2024
BUY
$40.38 - $50.75 $2.14 Million - $2.68 Million
52,890 Added 54.96%
149,117 $7.37 Million
Q4 2023

Feb 13, 2024
BUY
$24.89 - $43.41 $133,534 - $232,894
5,365 Added 5.9%
96,227 $4.03 Million
Q3 2023

May 14, 2024
SELL
$30.02 - $38.81 $161,057 - $208,215
-5,365 Reduced 5.58%
90,862 $2.98 Million
Q3 2023

Nov 14, 2023
BUY
$30.02 - $38.81 $331,991 - $429,199
11,059 Added 13.86%
90,862 $2.98 Million
Q2 2023

May 14, 2024
SELL
$26.7 - $37.02 $2.26 Million - $3.14 Million
-84,821 Reduced 51.52%
79,803 $2.82 Million
Q2 2023

Aug 14, 2023
SELL
$26.7 - $37.02 $2.26 Million - $3.14 Million
-84,821 Reduced 51.52%
79,803 $2.82 Million
Q1 2023

May 14, 2024
BUY
$26.64 - $39.74 $1.01 Million - $1.51 Million
38,002 Added 30.01%
164,624 $4.68 Million
Q1 2023

May 11, 2023
BUY
$26.64 - $39.74 $1.01 Million - $1.51 Million
38,002 Added 30.01%
164,624 $4.68 Million
Q4 2022

May 14, 2024
BUY
$38.78 - $46.78 $2.23 Million - $2.68 Million
57,379 Added 82.87%
126,622 $5.26 Million
Q4 2022

Feb 13, 2023
BUY
$38.78 - $46.78 $2.23 Million - $2.68 Million
57,379 Added 82.87%
126,622 $5.26 Million
Q3 2022

May 14, 2024
BUY
$30.9 - $50.65 $1.67 Million - $2.73 Million
53,973 Added 353.46%
69,243 $2.87 Million
Q3 2022

Nov 10, 2022
BUY
$30.9 - $50.65 $1.67 Million - $2.73 Million
53,973 Added 353.46%
69,243 $2.87 Million
Q2 2022

May 14, 2024
SELL
$29.23 - $44.45 $2.37 Million - $3.6 Million
-80,957 Reduced 84.13%
15,270 $499,000
Q2 2022

Aug 15, 2022
BUY
$29.23 - $44.45 $133,464 - $202,958
4,566 Added 42.66%
15,270 $499,000
Q1 2022

May 16, 2022
BUY
$16.89 - $35.74 $180,790 - $382,560
10,704 New
10,704 $375,000
Q4 2021

Feb 14, 2022
SELL
$24.6 - $46.29 $1.42 Million - $2.68 Million
-57,803 Closed
0 $0
Q3 2021

Nov 10, 2021
BUY
$35.91 - $41.94 $2.08 Million - $2.42 Million
57,803 New
57,803 $2.21 Million

Others Institutions Holding PRCT

# of Institutions
295
Shares Held
41.6M
Call Options Held
196K
Put Options Held
141K
View Full List

About PROCEPT BioRobotics Corp

PRCT Quotes by TradingView
  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $2.66B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email